METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA
Clinical trials for METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo combo tested to extend life in Hard-to-Treat stomach and esophageal cancers
Disease control Recruiting nowThis study tests whether a stronger chemotherapy mix (mFOLFIRINOX) works better than the standard mix (FOLFOX) for people with advanced stomach, esophageal, or gastroesophageal junction cancer that cannot be removed by surgery. Some participants also receive the immunotherapy dru…
Matched conditions: METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo targets stomach cancer protein in 100-Patient trial
Disease control Recruiting nowThis study tests whether adding the targeted drug zolbetuximab to standard chemotherapy (paclitaxel and ramucirumab) can help people with advanced stomach or gastroesophageal cancer live longer. It includes 100 adults whose tumors have a specific protein called CLDN18.2. Particip…
Matched conditions: METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for cancer patients with dangerous gene flaw: safer chemo combo tested
Disease control Recruiting nowThis study tests a different chemotherapy drug (trifluridine/tipiracil) for people with metastatic colorectal or gastroesophageal cancer who have a genetic condition (DPD deficiency) that makes standard chemo very toxic. About 73 participants will receive this drug along with oth…
Matched conditions: METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New scan could predict chemotherapy success in stomach cancer
Diagnosis Recruiting nowThis study is testing whether a special type of PET/MRI scan, using a tracer called FAZA, can measure low oxygen levels (hypoxia) in tumors of patients with metastasized gastro-oesophageal cancer. The goal is to see if this scan can predict how well patients will respond to stand…
Matched conditions: METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC